• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease.

作者信息

Kremer H P, Roos R A, Dingjan G, Marani E, Bots G T

机构信息

Department of Neurology, Leiden University Hospital, The Netherlands.

出版信息

J Neuropathol Exp Neurol. 1990 Jul;49(4):371-82. doi: 10.1097/00005072-199007000-00002.

DOI:10.1097/00005072-199007000-00002
PMID:2141871
Abstract

The hypothalamic lateral tuberal nucleus (NTL) was studied in the formalin-fixed brains of five patients with Huntington's disease (HD) and in five age- and sex-matched controls. With the Klüver-Barrera (luxol fast blue/cresyl violet) and hematoxylin and eosin stains the NTL was defined by its cytoarchitectonic characteristics. The nucleus was composed of one type of neuron and had about 60,000 cells. In HD, up to 90% neuronal loss was found in the NTL. The remaining neurons showed features of degeneration and there was astrocytosis. The estimated total number of glial cells in the NTL was reduced to 80% of the control values, which was exclusively accounted for by a reduction of 40% in the number of oligodendrocytes. The total number of astrocytes was unchanged. Grouping of astrocytes and the changes observed in glial fibrillary acidic protein immunocytochemistry suggested that astrocytic proliferation occurred.

摘要

相似文献

1
Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease.
J Neuropathol Exp Neurol. 1990 Jul;49(4):371-82. doi: 10.1097/00005072-199007000-00002.
2
The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease.
Neurosci Lett. 1991 Oct 28;132(1):101-4. doi: 10.1016/0304-3940(91)90443-w.
3
The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases.下丘脑外侧结节核:正常解剖结构及神经疾病中的变化
Prog Brain Res. 1992;93:249-61. doi: 10.1016/s0079-6123(08)64576-8.
4
Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients.生长抑素1 - 12免疫反应性在亨廷顿舞蹈病患者下丘脑外侧结节核中降低。
Brain Res. 1996 Jul 29;728(2):141-8. doi: 10.1016/0006-8993(96)00080-7.
5
Early loss of neostriatal striosome neurons in Huntington's disease.亨廷顿舞蹈病中新纹状体纹体神经元的早期丧失。
J Neuropathol Exp Neurol. 1995 Jan;54(1):105-20. doi: 10.1097/00005072-199501000-00013.
6
Connexin expression in Huntington's diseased human brain.亨廷顿氏病患者大脑中的连接蛋白表达
Cell Biol Int. 1998 Nov;22(11-12):837-47. doi: 10.1006/cbir.1998.0388.
7
A quantitative investigation of the substantia nigra in Huntington's disease.
Ann Neurol. 1989 Jul;26(1):13-9. doi: 10.1002/ana.410260103.
8
The hypothalamic lateral tuberal nucleus in Alzheimer's disease.阿尔茨海默病中的下丘脑外侧结节核
Ann Neurol. 1991 Mar;29(3):279-84. doi: 10.1002/ana.410290309.
9
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.亨廷顿病尾状核中神经元密度降低,少突胶质细胞密度增加。
J Neuropathol Exp Neurol. 1991 Nov;50(6):729-42. doi: 10.1097/00005072-199111000-00005.
10
Expression pattern of apoptosis-related markers in Huntington's disease.亨廷顿舞蹈病中凋亡相关标志物的表达模式。
Acta Neuropathol. 2005 Mar;109(3):321-8. doi: 10.1007/s00401-004-0957-5. Epub 2005 Jan 25.

引用本文的文献

1
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice.下丘脑中TDP-43的过表达会导致神经病理学变化、代谢失调并损害小鼠行为。
Acta Neuropathol Commun. 2025 May 27;13(1):119. doi: 10.1186/s40478-025-02018-8.
2
Neuroleptic malignant syndrome in Huntington disease.亨廷顿病中的神经阻滞剂恶性综合征。
Eur J Neurol. 2024 Dec;31(12):e16442. doi: 10.1111/ene.16442. Epub 2024 Oct 23.
3
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.亨廷顿舞蹈病中的细胞重排与氧化/抗氧化失衡
Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571.
4
Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.通过生物信息学分析探索 COVID-19 和神经退行性疾病之间的共享分子机制。
Int J Mol Sci. 2023 Mar 2;24(5):4839. doi: 10.3390/ijms24054839.
5
The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders.神经肽生长抑素在大脑中的作用及其在治疗神经系统疾病中的应用。
Exp Mol Med. 2021 Mar;53(3):328-338. doi: 10.1038/s12276-021-00580-4. Epub 2021 Mar 19.
6
Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?免疫反应是神经退行性疾病细胞治疗的瓶颈吗?
Front Cell Neurosci. 2020 Aug 11;14:250. doi: 10.3389/fncel.2020.00250. eCollection 2020.
7
No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington's disease.没有巴松管和短笛的交响乐:亨廷顿病中突触活性区蛋白的变化。
Acta Neuropathol Commun. 2020 Jun 3;8(1):77. doi: 10.1186/s40478-020-00949-y.
8
Glutamatergic fast-spiking parvalbumin neurons in the lateral hypothalamus: Electrophysiological properties to behavior.下丘脑外侧的谷氨酸能快速放电小白蛋白神经元:行为相关的电生理特性
Physiol Behav. 2020 Jul 1;221:112912. doi: 10.1016/j.physbeh.2020.112912. Epub 2020 Apr 11.
9
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.下丘脑病理学在亨廷顿舞蹈病非运动特征中的作用
J Huntingtons Dis. 2019;8(4):375-391. doi: 10.3233/JHD-190372.
10
Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.亨廷顿舞蹈症中的糖基化:一种可能的修饰因素及干预靶点
J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.